ilmscore | Prediction Details
"According to management estimates, this could lead to a 20% decline in revenues and a 30% decline in profits."
By Groww | June 25, 2025 | Pending
From video
3 Stocks With Better Fundamentals Than Their Valuation 00:10:48 - 00:10:52
Interpreted Prediction
Natco Pharma's management estimates a potential 20% decline in revenues and 30% decline in profits due to patent expiry.

Prediction Details

Ticker
NATCOPHARM

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.